Skip to main content
. 2012 Sep 18;55(12):1633–1641. doi: 10.1093/cid/cis783

Table 1.

Demographic and Clinical Characteristics of Extracorporeal Membrane Oxygenation Patients With and Without Nosocomial Infections

Variable Uninfected Patients, n = 78 Infected Patients, n = 142 P Value
Age, years 47.9 (15.1) 49.5 (16.9) .46
Male sex 57 (73) 90 (63) .14
SAPS IIa 60.4 (19.1) 61.3 (20.4) .76
SOFA scorea 11.6 (4.5) 12.6 (4.5) .17
Performance status ≥2 23 (30) 46 (33) .65
Body mass index, kg/cm² 25.2 (5.6) 25.3 (4.8) .85
McCabe score ≥2 37 (47) 57 (40) .29
Underlying conditionb
 Diabetes mellitus 9 (12) 26 (18) .19
 Renal insufficiency 1 (1) 5 (4) .33
 COPD 2 (3) 6 (4) .53
 Previous cardiac surgery 12 (15) 19 (13) .68
 Pregnancy or postpartum 3 (4) 1 (1) .09
 Immunocompromised statusc 15 (19) 49 (35) .02
Reason for ECMOd
 Dilated cardiomyopathy 16 (21) 18 (13) .58
 Myocarditis 14 (18) 16 (11) .68
 Acute myocardial infarction 11 (14) 31 (22) .04
 Cardiac arrest 11 (14) 17 (12) .66
 Postcardiotomy 23 (29) 55 (39) .16
 CABG 6 (8) 12 (8) .32
 Valve procedure 7 (9) 7 (5) .73
 CABG and valve procedure 0 2 (1) .18
 Heart transplantation 6 (8) 25 (18) .007
 Miscellaneous 4 (6) 9 (6) .28
 Other reasons 3 (4) 5 (4)
Site of ECMO cannulatione
 Extrathoracic only 45 (58) 54 (38) .005
Extrathoracic then intrathoracic 11 (14) 47 (33) .002
 Intrathoracic only 22 (28) 41 (29) .71
Location of the first ECMO cannulationf
 Operating room 33 (42) 73 (51) .20
 Catheterization lab 1 (1) 11 (8) .04
 ICU 32 (41) 33 (23) .006
 Mobile ECMO team 12 (15) 24 (17) .96
 ICU days before ECMO 1.4 (3.7) 2.2 (7.5) .35
 Hospital days before ECMO 7.7 (14.5) 6.2 (11.8) .41
 Antibiotics at the time of ECMO cannulationg 32 (41) 52 (37) .52

Data are No. (%) of patients or mean value (± standard deviation).

Abbreviations: CABG, coronary artery bypass graft; COPD, chronic obstructive airway disease; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; SAPS II, simplified acute physiology score; SOFA, sequential organ-failure assessment.

a Calculated at ICU admission.

b Global P value for underlying condition, P = .35.

c Includes patients with AIDs, solid organ transplantation, or hematological malignancy and those receiving chemotherapy, immunosuppressive agents, or long-term corticosteroid therapy.

d Global P value for reason for ECMO, P = .25.

e Global P value for site of ECMO cannulation, P = .004.

f Global P value for location of the first ECMO cannulation, P = .02.

g Includes patients who received prophylactic antibiotic therapy for central ECMO placement and those treated with antibiotics for an infection at the time of ECMO cannulation.